Research Article

Impact of Chronic Kidney Disease on Clinical Outcomes during Hospitalization and Five-Year Follow-Up after Coronary Artery Bypass Grafting

Table 6

Univariate analysis according to hospital mortality.

VariablesSurvivors (n = 399, 97.3%)Nonsurvivors (n = 11, 2.7%) value

Age (years)60 (55–68)63 (48–80)0.39
Diabetes mellitus (n, %)331 (83)7 (63.6)0.109
Hyperlipidemia (n, %)238 (59.6)7 (63.6)0.92
Hypertension (n, %)343 (86)8 (72.7)0.201
Bronchial asthma (n, %)43 (10.8)1 (9.1)1
CKD (n, %)112 (28.2)5 (45.5)0.01
PVD (n, %)43 (10.8)1 (9.1)1
Preoperative AF (n, %)24 (6)2 (18.2)0.15
Prior stroke (n, %)27 (6.8)1 (9.1)0.54
CAS (n, %)35 (8.8)2 (18.2)0.26
Prior MI (n, %)249 (62.4)8 (72.7)0.75
Prior cardiac surgeries (n, %)23 (5.8)4 (36.4)0.004
Type of surgeryIsolated CABG (n, %)365 (91.5)5 (45.5)<0.001
CABG plus valve surgery (n, %)34 (8.5)6 (54.5)
Emergency surgery (n, %)10 (2.5)3 (27.3)0.004
Cardiopulmonary bypass (minutes)100 (77–125)94 (89–168)0.33
Aortic cross-clamping (minutes)58 (43–82)59 (45–109)0.36
Exploration for bleeding (n, %)24 (6)3 (27.3)0.03
New onset AF (n, %)100 (25.1)9 (81.8)<0.001
Acute ischemic stroke (n, %)23 (5.8)7 (87.5)<0.001
Acute kidney injury (n, %)94 (23.6)11 (100)<0.001
New need for hemodialysis (n, %)14 (3.5)10 (90.9)<0.001
Peak lactate (mmol/L)5.4 (3.7–8.9)15.9 (8.3–16.6)<0.001
Peak troponin (ng/L)620 (391–1170)1250 (850–2350)0.003